Human FUS knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2
Drug discovery > Basic Research Products & Reviews
25
Products, services, reviews and techniques used in the preliminary investigations of the disease; the cell biology, genetics and protein pathways using tissue culture, cloning and imaging.
Selected Filters:
Human MLH1 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 12 and 1 bp deletion in exon 12 and 4 bp deletion in exon 12
Human Syp knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 8 bp deletion in exon 2
Human TGM2 knockout A549 cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 6
Human PHF6 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2
Human BRE knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 3
Human BAZ1A knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 11 bp deletion in exon 2
Human FOLR1 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 4 bp deletion in exon 1 and Insertion of the selection cassette in exon 1
Human IDH1 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 4
Human ATF3 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 2 and 5 bp deletion in exon 2
Human CNP knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 58 bp deletion in exon 2
Human CBS knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 11 bp deletion in exon 5 and 1 bp insertion in exon 5
Human PTEN knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 11 bp deletion in exon 5 and 5 bp insertion in exon 5 and Insertion of the selection cassette in exon 5
Human PTGS2 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2
Human PTK2 knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 4 and 17 bp deletion in exon 4
Human UCHL1 knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 45 bp deletion in exon 1
Human VDAC1 knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 2 bp deletion in exon 2
Human VIM knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2
Human TGFB1 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1
Human NF1 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1
Human EHMT2 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 7 and 370 bp deletion in exon 7
Human ENG knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 11 bp deletion in exon 2 and 19 bp deletion in exon 2 and 1 bp insertion in exon 2
Human TLE1 knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 13 bp deletion in exon 12 and Insertion of the selection cassette in exon 12
Human RALA knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2
Human CDK8 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and 22 bp deletion in exon 1